St. Jude's small ICD nets CE Mark

St. Jude Medical has received CE Mark approval of the Ellipse implantable cardioverter-defibrillator (ICD), which is smaller in design.

The Ellipse ICD’s shape, with its angled header and rounded edges, was conceptualized by physicians during focus groups in which they crafted in clay their vision, according to the St. Paul, Minn.-based company. The device contains new features in addition to the set provided in the Fortify ICD, including expanded ShockGuard technology for protection against inappropriate and unnecessary therapy, CorVue congestion monitoring and updated ST monitoring for ischemia-related ventricular arrhythmias.

Around the web

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.